Avista completes $4m facility expansion at former Microtest Labs

By Melissa Fassbender contact

- Last updated on GMT

Avista completes $4m facility expansion at former Microtest Labs

Related tags: Capital accumulation

The expanded facility features an additional 4,200 square feet of space to enhance its microbiology, sterility testing, and microbial ID service offerings.

The contract testing, development, and manufacturing organization (CDMO) announced the finished expansion at Interphex last week in New York.

The expanded facility features an additional 4,200 square feet of space to house a new microbiology laboratory and a modular cleanroom area, which features isolator technology and an ISO 6 cleanroom for sterility testing.

(Image: Avista Pharma)
(Image: Avista Pharma)

The site, formally Microtest Labs, has “an extensive client base through historical testing services as well as expanded services since being acquired by Avista Pharma​,” Patrick Walsh, CEO of Avista Pharma, told us.

We believe that continued investments in facility renovations, equipment, and services at this facility are important to maintain best-in-class service levels,​” he added.

Walsh further explained the new service offerings were requested by clients and the facility expansion “is necessary to keep pace with our intended growth targets​.”

Additional capabilities include isolator sterility testing, which enables Avista to provide sterility testing with comprehensive evaluations and a lower risk of false positives. 

This capability complements the services that we provide and is particularly sought by manufacturers such as parenteral pharmaceutical manufacturing clients​,” Walsh added.

Facility improvements also include a new microbiology laboratory and support area with new autoclaves and glassware washers.

We continue to invest in our existing service offerings and to rapidly expand new offerings​,” Walsh explained.

In addition to the expansion at its Agawam, MA facility, Avista is currently making investments at other Avista Pharma facilities, including increased scale of API manufacturing and solid dose finished product manufacturing at its Longmont, CO facility.

Related news

Related products

show more

INDENA ALWAYS AT THE FOREFRONT FOR CDMO SERVICES

INDENA ALWAYS AT THE FOREFRONT FOR CDMO SERVICES

Indena | 25-Oct-2022 | Technical / White Paper

Indena is well known in the space of naturally derived molecules, with a know-how developed over its one hundred year history. At the same time, the company...

dPCR Case Study

dPCR Case Study

CellCarta | 08-Aug-2022 | Case Study

Streamline your adoptive cell therapy program with digital PCR. Our team has a unique expertise in digital and quantitative PCR to support you in ensuring...

Flexible Filling Solution for CMOs

Flexible Filling Solution for CMOs

Single Use Support GmBH | 18-May-2022 | Insight Guide

Achieving flexibility requires modularity of technologies.

CMOs and CDMOs aspire to be flexible for multiple applications. Efficient automated...

Related suppliers

Follow us

Products

View more

Webinars